Dapriza M 10/500
Composition
Each Film Coated Bilayered Tablet Contains: - Dapagliflozin 10mg + Metformin 500mg in Extended-Release form
Indication
Dapriza M 10/500 is a combination medicine used to help manage type 2 diabetes more effectively. It contains two active ingredients: dapagliflozin 10 mg and metformin hydrochloride (ER) 500 mg tablets. Together, they work to lower high blood sugar levels and reduce the risk of diabetes-related complications.
Dapagliflozin 10mg + Metformin ER 500mg work in different but complementary ways. Dapagliflozin helps remove excess sugar from your body through urine. It acts on your kidneys and prevents the reabsorption of glucose back into your bloodstream, helping your body get rid of it naturally. This can also help with mild weight loss and lowering blood pressure.
Metformin, on the other hand, reduces the amount of sugar your liver produces, delays the absorption of sugar from the intestines, and improves your body’s response to insulin. This means your cells absorb more sugar from the bloodstream, which helps lower your overall blood sugar levels.
When combined in Dapriza M 10/500 tablets, these two ingredients offer better blood sugar control than when used individually. This makes Dapriza M 10/500 tab a powerful option for people managing type 2 diabetes. It's especially helpful when diet and exercise alone are not enough.
Always take the Dapriza M 10/500 tablet exactly as directed by your doctor and continue with healthy lifestyle habits for the best results.
Contraindication
Nausea, Vomiting, Diarrhoea, Genital fungal infection, Nasopharyngitis, Urinary tract infection, Polyuria, Flatulence.
Storage
Cool & Dry Place
Dosage
As directed by a Medical Practitioner or Physician.
Inquire Now